Posts tagged eliminating viruses
In Africa, Traditional Healers Can Undermine Efforts of Modern HIV Treatments
Imagine you start to show signs of possible HIV infection: your skin color changes, your immune system is visibly weaker than ever before, and a flu-like feeling just won’t go away. You go to your trusted healer, the traditional healer your family has seen for years, decades, possibly generations. Now, imagine this traditional healer tells you that these symptoms are not due to a blood-borne virus infecting your body, but by a curse a neighbor has placed upon you and your family. His or her treatment will not recommend antiretroviral medications, but to chant incantations and rub medical herbs into an open cut made from a razor. Although this is not heard of as a practice in any area of the United States, no matter how rural, this type of traditional healing is still very common in rural areas of Mozambique and other sub-Saharan African countries. When these traditional healers speak of curses and angered ancestors as the causes for the HIV symptoms, there is an inevitable delay between the first signs of symptoms and the administration of the first antiretroviral medicines. Prolonging this crucial timeframe shows that these traditional healers can undermine efforts of modern HIV treatments, which can harm the patient in irreparable ways, possibly causing the individual to develop AIDS before receiving the medicine he or she needs.
A study led by Carolyn Audet, Ph.D., an assistant professor of Health Policy, focused on sub-Saharan African countries. Over 60% of the rural residents in this study who started showing symptoms of HIV infection visited at least one traditional healer before consulting a trained medical professional, sometimes seeing several healers before any doctors. This caused, on average, a two-and-a-half-time longer delay for receiving the needed medicine, as over 50% of those who saw traditional healers first were initially diagnosed with having a curse placed upon them. With countries like Mozambique having over ten percent of its population infected with HIV (in the US it is roughly 0.6%), mistreatment has become an epidemic of serious concern. These delays can undermine efforts of modern HIV treatments, as many traditional healers are resistant to incorporating Western medicine into their religious and healing practices, which can seriously harm or even cause the preventable death of patients before receiving life-saving antiretroviral medicines.
New Anti-HIV Drugs
New Anti-HIV Drugs: Research in Stopping AIDS
In December of 2013, researchers at the University of Minnesota published some very striking and uniformly positive findings in the fight against HIV. They discovered several compounds that uniquely targeted HIV cells. These compounds – ribonucleoside analogs 8-azaadenosine, formycin A, 3-deazauridine, 5-fluorocytidine and 2’-C-methylcytidine – stop HIV replication by blocking DNA synthesis. This is achieved by causing the HIV cells to drop their DNA load before they are ready to and not within blood cells. The compounds also cause the HIV cells to mutate so rapidly that the cells essentially mutate themselves into extinction. The findings were a surprise to most of the anti-HIV research community, because the compounds in question were not on anyone’s radar. In fact, they seemed to have no potential for stopping HIV. Another major benefit to these compounds is the low cost of synthesizing them into new anti-HIV drugs. This is always an important factor, as it lessens the burden for the future prevention and treatment of HIV.
In fact, this is what has been occurring over the past year. The new anti-HIV drugs, which were synthesized version of these compounds, have been introduced in tangent with currently approved HIV medications. So far, the reports have been positive. Although the drugs do not fully eradicate HIV from an infected person’s system, the new drugs can be used along with lower doses of more expensive medications. With this tandem approach, the infection is kept low and extremely manageable. Having a minimal viral load results in low immune activity and prevents the virus cells from spreading throughout the body. Because of this symptoms are virtually absent. This translates into lower costs for a lifelong regimen of anti-HIV medication, both for the individual patients and for health care systems worldwide.
Life After AIDS
Life After AIDS: A Realistic Timetable
Up until 2001 and the advent of antiretroviral (ART) medications, HIV and AIDS was considered an epidemic, with death almost a certainty. Or, at least this was the case for those who were not wealthy or heavily covered by health insurance. AZT, the first popular antiretroviral drug, was extremely expensive. It was also only available in limited quantities, as manufacturers strained to produce enough of the drug for the needs of the worldwide population. This has all changed. Because of new research, a greater awareness of HIV, and insight into what the virus is and how it works, many scientists and doctors are reasonably hopeful in a future life after AIDS. In fact, some are even creating realistic timetables as to when this could be realized.
There is still no known cure for HIV infection. It is this virus – when left untreated – that causes acquired immune deficiency syndrome (AIDS). There are several drugs available today, however, which can either deactivate HIV cells or kill them outright. Through a regimen of these drugs, a person can survive with HIV for many years, even decades, without ever developing AIDS.
Moreover, this new phase of research into anti-HIV medications has resulted in an outpouring of education and understanding about the virus and disease. Certainly, the stigmas that were once attached to AIDS in the 1980’s have lessened. Because of the new treatments and changing attitudes, many have come forward to be tested who, in the past, might have assumed they would die and didn’t come forward for treatment to avoid the ‘shame’ of being HIV positive. Thanks to this domino effect of research and awareness the number of deaths from AIDS, although still unacceptably high, has been drastically reduced to 3 million per year. It has also led to fewer new infections from HIV, which numbers around 3.5 million per year.
In impoverished countries, those without adequate access to drug therapies, medical facilities, and proper HIV education, the number of deaths to AIDS along with new cases of HIV is still on the rise. This is the biggest hurdle to achieving the lofty goal of a life after AIDS. Even so, with the dramatic results in the past 13 years in countries like the United States, many are hopeful that by the later end of the 21st century, it is possible there will be no new infections. This will only happen when drugs have advanced to the point that they can completely sterilize the virus and when said drugs are accessible to everyone in the world.
Newest Case of an Apparent HIV Cure
Newest Case of An Apparent HIV Cure: Baby Shows Viral Reemergence
Last year a child in the southern United States known now as the ‘Mississippi Baby,’ received worldwide acclaim. The reason for the acclaim was it was the newest case of an apparent HIV cure, as the baby had had a complete viral remission of HIV. This child, born in 2010, was infected at the time of birth with HIV. The child was diagnosed as HIV positive, and was immediately given a highly concentrated treatment of antiretroviral therapy (ART). At 18 months old, the baby was no longer brought to the doctor for treatments or tests for five months, and when the child returned to the doctors they feared her HIV levels would be very high. Instead, the virus was undetectable. Along with a lack of HIV cells, there were no HIV antibodies present in the body. This seemed to be further “proof” to the scientific community of an apparent HIV ‘cure.’ Moreover, this prompted a worldwide study of intensive ART treatment.
Then, in Milan, Italy, a baby who was born HIV positive in 2009, was also thought to have been ‘cured.’ This baby had received intense ART shortly after the child’s birth and continued for three years. Again, there was no trace of HIV cells or of HIV antibodies in the child’s blood. After several months of these same results, ART treatment was stopped. Unfortunately, two weeks later the HIV tests became positive again, again illustrating that talk of a cure was premature.
In July, 2014 the ‘Mississippi Baby’ also tested positive for HIV. This was a major blow to the research in ART, and to the hope of completely eradicating any traces of HIV in a body. “It felt like a punch to the gut,” said Dr. Hannah Gay, a pediatric HIV specialist at the University of Mississippi Medical Center.
There are two other patients who were once considered cured of HIV, an anonymous patient and Timothy Ray Brown. As they were both treated in Berlin, they have been dubbed the ‘Berlin Patients‘ by many media outlets. But this newest case of an apparent HIV cure is not secure, as the anonymous patient has reverted to being HIV positive. However, this is not a roadblock; it is the start of a new push in research for achieving a true cure for HIV.
Interferon in HIV Treatment
Interferon in HIV Treatment: It Still Has Its Place
Interferons (IFN) are cells that are naturally produced in the body to fight against viral infections. When working as intended, interferons ultimately ward off and destroy the virus in the body. In fact, they are the main natural defense against cold and flu viruses. One major downside to interferon, though, is the harmful effects they have on the body while fighting viruses. You know that achy, nauseous feeling you get when you have the flu? Many of the symptoms equated with the flu actually don’t come from the virus itself; it comes from the effects of your body’s production of interferon cells. Interferon creates an inflammation in the body as it works, causing the ache that you experience. This negative side effect is a major reason why researchers have abandoned general use of interferon in HIV treatment.
Though this medication was used for several years as the only treatment of hepatitis C, new medications that have fewer side effects, a higher rate of success, and a shorter regimen period have replaced interferon treatment. However, in an attempt to keep the benefits of interferon treatment, researchers are trying to eliminate the negative side effects of IFNs while still keeping its effective virus-attacking properties intact. The results were mixed.
Researchers were successful in eliminating a majority of the side effects of IFN therapies, but they learned that when the inflammation is removed it affects interferon’s efficacy against viruses. It was also learned that interferon in HIV treatment, if given shortly after exposure to HIV, can be very effective—this despite the fact that general IFN treatment is still not the most effective way to manage HIV. Thus, it is important to keep in mind the type of treatment that an HIV patient is administered, and the timing of the treatment.